The strategic elements enabling Glycon to achieve its stated mission are:
The commercial market opportunities targeted by Glycon are more than sufficient to attract licensing and/or cooperative development agreements with leading pharmaceutical companies.
The development strategy consists of using its patented platform technologies in developing new pro-drugs, new delivery systems for pharmaceuticals and new compositions of matter useful in prescription and non-prescription drugs.
Each platform technology has multiple drug candidates thereby optimizing opportunities for successful pharmaceutical partnering.
Glycon continues to seek licensing and/or cooperative development agreements with pharmaceutical companies.
Glycon is actively seeking licensing and or co-development partners for the continued development of its potential drug candidates.